ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 20 analysts with an average price target of $31.38. This is a potential upside of $6.06 (23.93%) from yesterday's end of day stock price of $25.32.

ACADIA Pharmaceuticals's activity chart (see below) currently has 405 price targets and 326 ratings on display. The stock rating distribution of ACAD is 70% BUY, 28.75% HOLD and 1.25% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.76% with an average time for these price targets to be met of 228.03 days.

Highest price target for ACAD is $38, Lowest price target is $17, average price target is $27.58.

Most recent stock forecast was given by JASON BUTLER from JMP on 07-Aug-2025. First documented stock forecast 06-May-2013.

Currently out of the existing stock ratings of ACAD, 56 are a BUY (70%), 23 are a HOLD (28.75%), 1 are a SELL (1.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$38

$12.26 (47.63%)

$37

18 days ago
(07-Aug-2025)

9/17 (52.94%)

$13.6 (55.74%)

238

Hold

$24

$-1.74 (-6.76%)

$23

18 days ago
(07-Aug-2025)

9/13 (69.23%)

$-0.4 (-1.64%)

171

Sell

$17

$-8.74 (-33.95%)

$12

18 days ago
(07-Aug-2025)

4/7 (57.14%)

$-7.4 (-30.33%)

186

Buy

$34

$8.26 (32.09%)

$30

1 months 1 days ago
(24-Jul-2025)

6/10 (60%)

$10.95 (47.51%)

106

Buy

$32

$6.26 (24.32%)

$32

1 months 30 days ago
(26-Jun-2025)

7/23 (30.43%)

$9.79 (44.08%)

118

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 228.03 days on average for the stock forecasts to be realized with a an average price target met ratio 65.76

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov works at EVERCORE and has 8 price targets and 6 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $34.26

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Chris Howerton with lowest potential downside - -$10.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?